Myriad Genetics, Inc.
NASDAQ:MYGN
Overview | Financials
Company Name | Myriad Genetics, Inc. |
Symbol | MYGN |
Currency | USD |
Price | 17.67 |
Market Cap | 1,604,796,468 |
Dividend Yield | 0% |
52-week-range | 16 - 29.3 |
Industry | Diagnostics & Research |
Sector | Healthcare |
CEO | Mr. Paul J. Diaz |
Website | https://myriad.com |
An error occurred while fetching data.
About Myriad Genetics, Inc.
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing the
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD